Sanofi Digital Transformation and Self Medication_mHealth Israel

•

0 likes•261 views

Presentation by Dr. Caty Ebel Bitoun, Global Medical Digital Transformation Head, Sanofi, for the mHealth Israel community, April 12, 2021. Begins with an overview and description of Sanofi worldwide. Explanatio of Sanofi's three Global Business Units (GBU) focused on prioritized portfolio. 1st GBU is Specialty Care: Immunology, Rare Diseases / Rare Blood Disorders, Neurology / Multiple Sclerosis, Oncology; 2nd GBU is General Medicines: Diabetes, Cardiovascular, Established Products; 3rd GBU is Vaccines: Influenza vaccines, Polio Pertussis & Hib, Boosters, Meningitis, others. There is also a standalone GBU for Consumer Healthcare: Allergy, Cough & Cold, Pain, Digestive Health, Mental Wellness. Digital is changing the healthcare landscape. Empowering patients / consumers and organising self monitoring. Digital improves patient information and product usage with sustainibility value proposition. Digital Therapeutics are opening a new way to manage pain. Sanofi Ideal partner profile has Mature technology including mature business model. Scalable across more than 2 geographies. Compliance with cybersecurity and data protection. Sustainibility value proposition. Easy to purchase (onsite & e-commerce). Impact on consumers includes Consumer focus. Proven improvement in health or lifestyle outcome. Data driven claims supported by scientific evidence. Augmented consumer experience. Sanofi has a partner centric philosophy.

Health & Medicine

How Digital
Transformation
creates new
opportunities
for
self-medication
Dr Caty Ebel Bitoun
CHC Global Medical Digital
Transformation Head
April 12th 2021

Who we are
2
AROUND THE WORLD OUR TEAMS
100,000+
employees
46.2%
women
53.8%
men
~145
nationalities
We are present in
~100 countries
Healthcare solutions available in more than
170 countries
TRANSTECH HEALTH APRIL 12TH 2021

Sanofi Global Business Unit (GBU) organization
3
3 CORE GBUs FOCUSED ON PRIORITIZED PORTFOLIO
Specialty Care
— Immunology
— Rare Diseases /
Rare Blood Disorders
— Neurology /
Multiple Sclerosis
— Oncology
General Medicines
— Diabetes
— Cardiovascular
— Established Products
Vaccines
— Influenza vaccines
— Polio Pertussis & Hib,
Boosters
— Meningitis, others
STANDALONE GBU
Consumer Healthcare
— Allergy, Cough & Cold
— Pain
— Digestive Health
— Mental Wellness
TRANSTECH HEALTH APRIL 12TH 2021

Sanofi CHC is leading in 4 global OTC categories
TRANSTECH HEALTH APRIL 12TH 2021

Digital is changing the healthcare landscape
Empowering patients / consumers and organising self monitoring
5
TRANSTECH HEALTH APRIL 12TH 2021
https://www.efpia.eu/about-medicines/development-of-
medicines/digital-health/

How digital improve patient information and product usage
with sustainibility value proposition
TRANSTECH HEALTH APRIL 12TH 2021
https://www.sanofi-diabete.fr/notre-
engagement/actualites/diab-voyage

7
A concrete example from Sanofi France
Digital Therapeutic : Opening a new way to manage pain
TRANSTECH HEALTH APRIL 12TH 2021

8
A concrete example from Sanofi Venture & Alive Israel HealthTech fund
Beyond the pill : How digital helps to self manage medication
TRANSTECH HEALTH APRIL 12TH 2021

Sanofi has a partner centric philosophy
TRANSTECH HEALTH APRIL 12TH 2021

THANK YOU
Contact:
Dr Caty Ebel Bitoun
Caty.ebel-bitoun@sanofi.com

Presentation by Michele Holcomb, EVP, Chief Strategy & Business Development Officer, Cardinal Health, May 19th, 2021 for mHealth Israel. The pandemic accelerated and intensified key trends. Patients are more proactive in their health, Providers are taking a more holistic approach, Digital acceleration is unlocking opportunities. Patients are more proactive in their health. Online searching for health information continues to rise. People say looking up their symptoms is overwhelming, but they can’t stop. U.S. adults go online to identify a medical condition. Telehealth and home-based healthcare jumps. Telehealth makes up ~10% of physician visits; up from <1% of physician visits pre-pandemic. Hospital at home companies like Medically Home cared for 10X more patients. On-line pharmacy market accelerates. The North America online pharmacy market estimated at $31B in 2020 and it’s expected to grow 18.2% CAGR from 2020-2027. Providers are taking a more holistic approach. Social determinants of health have come into sharp focus. Economic stability, Physical environment, Education, Food Security, Community and Social Context, Healthcare Access. U.S. Population vs. COVID-19 cases. Race gaps in COVID-19 death rates. Mental health challenges escalate across the population. Significant rise in adults aged 65+ reporting anxiety or depression. More women compared to men are reporting significant increases in depression. Mental health related ER visits in youth are rising. Digital acceleration is unlocking opportunities faster than ever. Growth of digital health continues to set new records. The new gold rush: retrieving, analyzing, and leveraging data. “Most interesting” health tech M&A deals in 2020. Data and analytics critical across healthcare. Half of healthcare organizations are already using patient data predictive analytics. One third of the world’s data production (750 quadrillion bytes of data) is generated in healthcare everyday. Artificial intelligence set to transform treatment. The number of active AI startups has increased 14-fold since 2000. The healthcare AI powered tools market will exceed $34 billion by 2025.

HiHealth.io

Hi:Health

Ethics, Informatics and Obamacare

Barry Smith

Surveys a series of ethical, economic, clinical and also safety issues relating to the application of informatics to healthcare, focusing especially on the role of informatics in the Patient Protection and Affordable Care Act. Talk presented in the University at Buffalo Clinical/Research Ethics Seminar - Ethics, Informatics and Obamacare, November 20, 2012. Slides are available here: http://ontology.buffalo.edu/13/ethics-informatics-obamacare.pptx

Health-Tech: Endless opportunities & endless disruption

Anirban Bhattacharjee

Mobile Health at Ochsner: The Apple HealthKit and Epic EMR Integration

Rahlyn Gossen

Healthcare Nous InfoSystem

Ujjwal Anand

European Journal Epractice Volume 8.4ePractice.eu

New Global Healthcare Another Chapter In Healthcare Marketing Brand Management

JGB1

Collaborated with the Mayo Clinic's Centre for Innovation on a team project to envision a 2035 future for specialized healthcare providers. Researched trends and drivers from a social, technological, economic, political, environment and values perspective and applied strategic foresight/futures methods to create possible future outcomes. Designed strategies to influence a positive future and mitigate against negative outcomes. The final report was used by the clinic as an innovation input for their multi-year strategic planning activities.

Mobile Health Technologies: Future Tools of Healthcare

David Lee Scher, MD

Digital Healthcare Trends: Transformation Towards Better Care Relationship

Kumaraguru Veerasamy

Digital health encompasses digital care programs, technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and to make medicine more personalized and precise. With the increasing adoption of telemedicine, wearable devices, mobile health apps (especially during the recent COVID-19 pandemic) and VR/AR; digital health is poised to take healthcare forward.

mHealth Israel_Impact of Digital Innovations on Healthcare in Asia: 2020_Finn...

Levi Shapiro

Report by Finn Partners: Impact of Digital Innovations on Healthcare in Asia- 2020. Deep-dive analysis across healthcare delivery, healthcare financing and healthcare discovery. Sections include Healthcare in the Digital Age, Digital health brings patient care to where it is needed the most, Innovative fintech solutions deliver affordable healthcare to Asia, More data and better insights delivered by AI and machine learning, Digital health is the future.

Healthcare

Mobiloitte

Dynamics Impacting the Future of Healthcare

ams345

Health, Wellness & Wearables

Tsahia Hobson, MHA

MANAGEMENT INFORMATION SYSTEM

AvantikaGupta33

Sensotrend Pitch for SeedForum - DRAFT

Mikael Rinnetmäki

Many times, pitch events have their own rules or guidelines for the pitch. They may limit the number of slides or even give you a full structure of the pitch that you need to follow. Before the actual event, there may be a session where the pitches are prepared and modified according to feedback from coaches and peers. Time for modifications is often really limited, so don't concentrate on making it as beautiful as possible, rather just testing out raw ideas and see what kind of a feedback they get.

Obama care a new opportunity in us healthcare - finpro

Business Finland

Future Trends in Healthcare

Farhad Zargari

Healthcare in future will not be like today. The changes are dramatic and paradigmatic. In this presentation we will see some the mega trends influencing this field. Future Trends, Population Increase, Aging, Urbanization, Individualization and health awareness, Consumerism, Shifting Economy, Technological Progress, Climate Change and Environmental Pollution, Shifting Disease Patterns, lifestyle diseases, high-calorie diet, physical inactivity and higher levels of stress, Decline in muscular, skeletal and infectious diseases, Better-informed Patients, Decline in information asymmetry, Internet, Social Networks, Self care, home care, self-medication, New Health Markets, Pharma, economy, pharmerging countries, Growing Competition, Brand, Generic, Innovative, HighTech, Increasing Cost Pressure, Aging, Better Access, Complex Supply Chains, R&D outsourcing, Complex Products, supply chains, Product Development, Innovation, Pharmacogenomics, Therapeutic Vaccines, Regenerative medicine, 3D Printing, Robot-assisted surgeries, Mobile health,Tele-medical applications, Direct-to-consumer (DTC ) distribution, Direct-to-consumer (DTC ) advertisement, OTC Growth, home delivery, prescription drugs,

Oviva - NOAH19 Berlin

NOAH Advisors

20191203 DOE Data Driven Healthcare- Expert Event

DayOne

DayOne Experts - Data-driven healthcare – are we ready? Data is transforming healthcare. Health data from multiple sources such as electronic health records, genomic testing, imaging and digital tools, combined with advanced analytics can be used to deliver more personalised care, improve outcomes, empower patients and make healthcare more sustainable and efficient. But is the industry ready for these new approaches? What is needed on the policy level and in the regulatory field to enable a new era of data driven health solutions? How will their business models look like? This is what we discussed at this DayOne Expert Event, which was proudly presented in close collaboration with the Embassy of the Netherlands, fostering the exchange between two world leading healthcare innovation ecosystems.

What's hot

Latest Trends in Healthcare

Startup Ecosystem

Research & Development of Digital Therapeutics

daVinci Digital Therapeutics

Can ehealth solve China's Healthcare challenges (McKinsey presentation)Franck Le Deu

policy-iot-healthcareMichael Jackson

Future trends in global healthcareCongreso Internacional Cirugía Bariátrica y Metabólica

Aicube persona al centro del progresso

Stefano Russano

China Healthcare Overview

Ammar

WV transformation slide show may conference2

Jack Shaffer

China tencent MJMichael Jackson

Dossier health care final

Uma Maharaj

Mobile Health Technologies: Future Tools of Healthcare

David Lee Scher, MD

Digital Healthcare Trends: Transformation Towards Better Care Relationship

Kumaraguru Veerasamy

mHealth Israel_Impact of Digital Innovations on Healthcare in Asia: 2020_Finn...

Levi Shapiro

Healthcare

Mobiloitte

Dynamics Impacting the Future of Healthcare

ams345

Health, Wellness & Wearables

Tsahia Hobson, MHA

MANAGEMENT INFORMATION SYSTEM

AvantikaGupta33

Sensotrend Pitch for SeedForum - DRAFT

Mikael Rinnetmäki

Obama care a new opportunity in us healthcare - finpro

Business Finland

Future Trends in Healthcare

Farhad Zargari

What's hot (20)

Latest Trends in Healthcare

Research & Development of Digital Therapeutics

Can ehealth solve China's Healthcare challenges (McKinsey presentation)

policy-iot-healthcare

Future trends in global healthcare

Aicube persona al centro del progresso

China Healthcare Overview

WV transformation slide show may conference2

China tencent MJ

Dossier health care final

Mobile Health Technologies: Future Tools of Healthcare

Digital Healthcare Trends: Transformation Towards Better Care Relationship

mHealth Israel_Impact of Digital Innovations on Healthcare in Asia: 2020_Finn...

Healthcare

Dynamics Impacting the Future of Healthcare

Health, Wellness & Wearables

MANAGEMENT INFORMATION SYSTEM

Sensotrend Pitch for SeedForum - DRAFT

Obama care a new opportunity in us healthcare - finpro

Future Trends in Healthcare

Similar to Sanofi Digital Transformation and Self Medication_mHealth Israel

Oviva - NOAH19 Berlin

NOAH Advisors

20191203 DOE Data Driven Healthcare- Expert Event

DayOne

2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014

IKT-Norge

MSD Policy Passport on pharmaceutical innovation - October 2023 v2.pdf

Boris Azaïs

20130226 impact van zorg 2 0 op onze samenlevingD3 Consutling

20130226 impact van zorg 2 0 op onze samenlevingAnn Huygelier

Agata Jakoncic, 2nd Health Innovation Conference

Starttech Ventures

The Establishment of  a Diabetes Department

dr-nabhan

Gian Piero Reverberi - Overview of the diabetes - e-health 6.6.14Thearkvalais

AI for Physicians In4care Domus Medica

Bart Collet

Silver Economy Netherlands Telehealth Chronic Illnessguest2b28a5

Caring for People with Chronic Illness: The Role of Telehealth Technology

Steve Brown

Future of Health & Wellbeing- Key trends and business opportunities

Danilo Mazzara

GenSearch - Innovation in Healthcare: What is the Point?

Alix Aubert

In this white paper, you will discover instances where innovation in technology and organisational operations are connecting patients to healthcare providers and are sharing secure clinical data with researchers. Others have disrupted traditional manufacturing methods to improve processes and some have even transformed organisational operations to create customer trust, value, and to improve outcomes for patients.

#MWC15Health joe killen tunstall

3GDR

Innovation For Health by DSM Chief Innovation OfficerDSM

Andrew Powrie-Smith (EFPIA) for European Patients' Rights Day

Cittadinanzattiva onlus

Hypertension management will change more in the next 5 years than in the last...

Valencell, Inc

Why will managing hypertension change more in the next 5 years than it has in the last 100? There are several macro trends that are driving this change: - Hypertension is a massive global health problem (over 1B people have high BP) and it is THE leading risk factor for the global burden of disease (its a comorbidity in every major chronic disease) - more of a risk factor than tobacco, obesity, poor diet, high blood glucose, etc. - according to the WHO. - Sensor tech - there has been no meaningful innovation in BP sensors in over 100 years. The BP cuffs in use today are fundamentally the same as the first BP cuff that came to market in the early 1900's. That’s changing now with cuffless BP sensors that are being approved by regulatory bodies. - Care delivery – healthcare "has left the building", moving out of the hospital, into the home and everyday life. This can be seen in the huge growth in remote patient monitoring, digital therapeutics, and digital health more broadly. - Payer models – insurance coverage is moving from fee-for-service to value-based care that’s focused on prevention and monitoring. This is particularly important in hypertension management because high BP has no outward symptoms, making the frequency and ease of BP monitoring extremely important.

Chapter 17 TelemedicineRobert Hoyt MDThomas Martin PhD.docx

zebadiahsummers

Chapter 17: Telemedicine Robert Hoyt MD Thomas Martin PhD Learning Objectives After reviewing the presentation, viewers should be able to: State the difference between telehealth and telemedicine List the various types of telemedicine consultations, such as teleradiology and teleneurology List the potential benefits of telemedicine to patients and clinicians Identify the different means of transferring information with telemedicine, such as store and forward Discuss the most significant ongoing telemedicine projects Definitions Telehealth: The use of electronic information and telecommunications technologies to support long-distance clinical health care, patient and professional health-related education, public health and health administration Telemedicine: “the use of medical information exchanged from one site to another via electronic communications to improve patients' health status” or simply the remote delivery of healthcare Popularity of Telemedicine Rising cost of healthcare worldwide new strategies (telemedicine) to prevent readmissions Shortage of specialists in rural areas Rise in chronic diseases and aging of population Improved collaboration among physicians and disparate healthcare organizations Raises patient satisfaction when it results in better access to specialty care Electronic Telemedicine Modes Radio Doctor—predicted in 1924 TV Telephone Internet Telemedicine Communication ModesCommunication ModeProsConsPatient-Portal Secure messagingAsynchronous. Able to attach photos. Response can be formatted with template. Could use VoIP. Audit trail is availableNot as personal as live visit. Usually not connected to EHR or other enterprise information but may be in the futureTelephoneWidely available, simple and inexpensive. Real-timeNot asynchronous. Unstructured. No audit trail. Only real-timeAudio-VideoMaximal input to clinician. Can include review of x-rays, etc. Perhaps more personal than just messagingCurrently, most expensive in terms of networks and hardware, but that is changing Telemedicine Transmission Modes Store-and-forward Images or videos are saved and sent later Asynchronous communication Real time A specialist views video images transmitted from a remote site and discusses the case with another physician Requires more sophisticated equipment: two way interactive telemonitors permit the specialist to see and talk to the patient Remote monitoring Monitor patients at home or in a nursing home; usually part of disease management Telemedicine Categories (Author’s classification) Televisits: Teleconsultations: Teleradiology, teledermatology, teleneurology, telepharmacy Telemonitoring Telerounding: hospital inpatients Telerobots eICUs Telehomecare: monitoring physiological parameters, activity, diet, etc. at home Teleconsultation is a worldwide phenomenon because specialists tend to practice in large metropolitan areas, and not i.

The Forecast // Health & Wellness

Usbek & Rica Trends

Similar to Sanofi Digital Transformation and Self Medication_mHealth Israel (20)

Oviva - NOAH19 Berlin

20191203 DOE Data Driven Healthcare- Expert Event

2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014

MSD Policy Passport on pharmaceutical innovation - October 2023 v2.pdf

20130226 impact van zorg 2 0 op onze samenleving

Agata Jakoncic, 2nd Health Innovation Conference

The Establishment of  a Diabetes Department

Gian Piero Reverberi - Overview of the diabetes - e-health 6.6.14

AI for Physicians In4care Domus Medica

Silver Economy Netherlands Telehealth Chronic Illness

Caring for People with Chronic Illness: The Role of Telehealth Technology

Future of Health & Wellbeing- Key trends and business opportunities

GenSearch - Innovation in Healthcare: What is the Point?

#MWC15Health joe killen tunstall

Innovation For Health by DSM Chief Innovation Officer

Andrew Powrie-Smith (EFPIA) for European Patients' Rights Day

Hypertension management will change more in the next 5 years than in the last...

Chapter 17 TelemedicineRobert Hoyt MDThomas Martin PhD.docx

The Forecast // Health & Wellness

More from Levi Shapiro

Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...

Levi Shapiro

June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...

Levi Shapiro

Letter from the Congress of the United States regarding Anti-Semitism sent June 3rd to MIT President Sally Kornbluth, MIT Corp Chair, Mark Gorenberg Dear Dr. Kornbluth and Mr. Gorenberg, The US House of Representatives is deeply concerned by ongoing and pervasive acts of antisemitic harassment and intimidation at the Massachusetts Institute of Technology (MIT). Failing to act decisively to ensure a safe learning environment for all students would be a grave dereliction of your responsibilities as President of MIT and Chair of the MIT Corporation. This Congress will not stand idly by and allow an environment hostile to Jewish students to persist. The House believes that your institution is in violation of Title VI of the Civil Rights Act, and the inability or unwillingness to rectify this violation through action requires accountability. Postsecondary education is a unique opportunity for students to learn and have their ideas and beliefs challenged. However, universities receiving hundreds of millions of federal funds annually have denied students that opportunity and have been hijacked to become venues for the promotion of terrorism, antisemitic harassment and intimidation, unlawful encampments, and in some cases, assaults and riots. The House of Representatives will not countenance the use of federal funds to indoctrinate students into hateful, antisemitic, anti-American supporters of terrorism. Investigations into campus antisemitism by the Committee on Education and the Workforce and the Committee on Ways and Means have been expanded into a Congress-wide probe across all relevant jurisdictions to address this national crisis. The undersigned Committees will conduct oversight into the use of federal funds at MIT and its learning environment under authorities granted to each Committee. • The Committee on Education and the Workforce has been investigating your institution since December 7, 2023. The Committee has broad jurisdiction over postsecondary education, including its compliance with Title VI of the Civil Rights Act, campus safety concerns over disruptions to the learning environment, and the awarding of federal student aid under the Higher Education Act. • The Committee on Oversight and Accountability is investigating the sources of funding and other support flowing to groups espousing pro-Hamas propaganda and engaged in antisemitic harassment and intimidation of students. The Committee on Oversight and Accountability is the principal oversight committee of the US House of Representatives and has broad authority to investigate “any matter” at “any time” under House Rule X. • The Committee on Ways and Means has been investigating several universities since November 15, 2023, when the Committee held a hearing entitled From Ivory Towers to Dark Corners: Investigating the Nexus Between Antisemitism, Tax-Exempt Universities, and Terror Financing. The Committee followed the hearing with letters to those institutions on January 10, 202

Prix Galien International 2024 Forum Program

Levi Shapiro

June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels: - ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING - WOMEN’S HEALTH: FERTILITY PRESERVATION - WHAT’S NEW IN THE TREATMENT OF INFECTIOUS, ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES? - ARTIFICIAL INTELLIGENCE AND ETHICS - GENE THERAPY - BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE - ETHICAL CHALLENGES IN LIFE SCIENCES - Prix Galien International Awards Ceremony

mHealth Israel_Healthcare Finance and M&A- What Comes Next

Levi Shapiro

Healthcare Finance and M&A, What Comes Next? Presentation by Matthew R. Kittay, National Co-Chair, M&A Practice Group, Fox Rothschild LLP. Includes fundraising and investments. Breakouts by subsector- Healthcare (overall), Healthcare services, Digital health, Biopharma, Pharmatech, Medtech, Healthcare IT. Healthcare transaction distribution breakouts. Exits remain flat. Avoiding common legal pitfalls like IP, compliance, governance structure. Current legislation in health law. IP strategy for healthtech.

Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...

Levi Shapiro

Oppenheimer & Co. Inc, co-Head of Healthcare Investment Banking, Michael Margolis, provides H1 Healthcare Financing, Funding and M&A Overview. Table of Contents 1. Broader Market Overview 2. Biotech M&A Market Overview 3. Private Biotech Financing Market Update 4. Key Advice For Healthcare Companies Current State of Play; Healthcare has Underperformed the Broader Market Over the Last Twelve Months; Signal-to-Noise is Getting Worse; Healthcare IPO Activity has Decreased Significantly Since 20–21 Pandemic Levels; Biotech Financing Activity Has Remained Robust in 2024; Biotech M&A Market Remains Incredibly Active; Biotech M&A Market Remains Incredibly Active; Big Pharma Upcoming Patent Expirations; Since November 2023 Oncology has accounted for over half of all M&A; Oncology, Autoimmune / I&I, and CV & Metabolic Remain the Top Areas in M&A; Small Molecule Beats Out All Other Modalities in M&A Despite IRA Concerns; Value of Big Pharma Acquisitions by Therapeutic Area in Q1 2024; Private Financing Market Update; 2024 Private Placement Activity On Track to Approach, If Not Exceed, 2020 Levels; Oncology, Particularly Solid Tumor, Continues to Attract VC Investors; Despite the IRA, Small Molecules Continue to Attract VC Dollars; Preclinical-Stage Companies Make Up Almost Half of Private Placements in 2023; Valuations by Development Stage – 2023; Typical Biotech Investors Remained Active in Q1 2024; 23 $100M+ Deals were Raised in Q1 2024; Biotech Fundraising Momentum Continued into 2024; Key Advice For Israeli Healthcare Companies; Although Israel has Strong Presence on US Public Markets, There is Room to Grow; Telling Your Story Effectively; Interacting with Investors to Build Long-term Credibility; Seven Simple Rules for Pitch Decks;

Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003

Levi Shapiro

Radical Life Extension_Dr. Leon Peshkin_Dec 2023

Levi Shapiro

Presentation for mHealth Israel by Dr. Leon Peshkin, Harvard Medical School, exploring research into Embryology and Longevity, emphasizing Germline and protein aggregates. Includes current overview, anti aging through history, Lifespan Expansion, ALEC: Animal Life Expectancy in Controls, Scalable Platform in Pharmacobiology, Embryos Cleanse Protein Aggregates, Lysosomal switch triggers proteostasis renewal, Xenopus, Rejuvenation Roadmap, Citizen Science Approach to Aging, Xenopus: Maternal Dowry Molecules, Human Disease Modeling

Israel’s Life Science Hub 2023 English Abstract.pdf

Levi Shapiro

The war between Israel and Hamas brings its own set of business challenges. Challenges that may impact how we communicate with partners and investors abroad. We should portray the life science sector as resilient and adaptable, even in times of crisis. This document is a a messaging outline for Israel's Life Science Hub despite the war with Hamas. Four key points to emphasize: 1) Global activity (resilience and agility) 2) Continuity of care and preventive medicine 3) World leading clinical trials industry 4) Dynamic scientific, research and entrepreneurial ecosystems

Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...

Levi Shapiro

The Future of Digital Health – Nose Dive or Transformation, by Gil Bashe, Dec 4th, 2023 at the mHealth Israel conference. Digital Health Innovation Ecosystem Investment Trends. Data & Methodology. Digital Health Taxonomy. Key Insights for Digital Health Innovation in H1 2023. Global Digital Health Funding Across Regions. Funding in North America. Shifting Focus in North America Digital Health Funding. Investment Focus for Digital Health Venture Funding. Ventures are turning to partnerships for proof points, scale and funding. 2022 new partnerships. North America digital health investor participation. Most active partners in North America. North America Ecosystem Development. Venture distribution by stage. Funding distribution. Comparison to 2022 Funding. Noteworthy deals, noteworthy exits.

Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT

Levi Shapiro

We, 465 MIT Alumni, Staff, and Students, are writing to express our deep concern, fear, and disappointment regarding the recent protest that took place Thursday afternoon, in front of the MIT Stratton Student Center. While we fully support the principles of free speech and the right to peaceful assembly, it is essential that we also prioritize the safety and well-being of all members of the MIT community. During the protest, a particular slogan was prominently displayed and chanted, which has raised significant concerns. The slogan "From the [Jordan] river to the [Mediterranean] sea, Palestine will be free!" has been a source of contention due to its potential implications and the real safety risks it poses to Jewish and Israeli students on campus [See video footage attached]. This slogan has been time and again associated with calls for the destruction of the State of Israel and has been used in contexts that promote violence, which raises legitimate concerns about the safety and security of our Jewish and Israeli students and staff. Furthermore, we would like to draw your attention to recent events that demonstrate the potential dangers associated with this slogan. During the 2023 Israel-Hamas war, British Home Secretary Suella Braverman proposed criminalizing the use of the slogan in certain contexts, recognizing the potential harm it can cause. Additionally, on October 11, ‘23, Vienna police banned a demonstration, citing the inclusion of the phrase "from the river to the sea" in invitations, as it was seen as a portrayal of a violation of Article 2 of the European Convention on Human Rights. In addition to the use of these derogatory messages, several attendees of the event used hateful wordings and messages towards Jewish and Israeli bystanders. In one case, a perpetrator aggressively held their bicycles as intended to harm a Jewish MIT student, stating that “[your] ancestors did not die in the Holocaust so they could kill Palestinians” [See video footage attached]. In another incident, protesters chanted “one solution, intifada revolution”. In the context of the on-going Israeli-Palestinian conflict, the word "Intifada" means the armed and violent Palestinian insurrection targeting Israelis, including civilians, which resulted in the killing of thousands of Israelis in the last few decades. On Oct. 22nd, a statement by MIT CAA (Coalition Against Apartheid) came to our attention. In this document, MIT CCA states that they "hold the Israeli regime responsible for all unfolding violence". They later call the October 7th terror attack a "response to the settler colonial regime", and continue justifying it throughout the document. In this matter, MIT CAA is justifying the heinous and barbaric crimes committed on Oct 7th. Furthermore, these statements have the potential to fuel acts of aggression

HLTH-2023-Digital-Catalouge.pdf

Levi Shapiro

Overview of the Israeli exhibitors at the 2023 HLTH conference in Las Vegas. Exhibitors included 6Degrees, AppScent, Belong.Life, Datos, Expecting, IntraPosition, Kahun Medical, Kemtai, Maverick, Neteera, QuantaIX, Respiration Scan, Nerivio, Xoltar. 40% of Israeli technology investment is devoted to Life Science. Within that domain, the largest sector is Medical Devices and Digital Health (over 65 percent of companies). In the medical device arena, Israeli scientists and engineers have integrated advanced technologies in electronics, communications and electro-optics to develop world-class innovations in Digital Imaging, Medical Lasers, Telemedicine, Early Diagnostics, Smart Surgical Equipment and more. Over 600 medical device exporters engaged in a variety of medical application such as Cardiovascular and Peripheral Vascular, Neurology and Degenerative Diseases, Preparedness and Emergency Medicine, Intensive Care, Women Health, Orthopedics and Sport Medicine, Gastrointestinal, Infection Control, Ophthalmology, Pain and Wound Management, Oral and Dental Care, Dermatology and Aesthetics

Baptist Health- Engineering the Future of Healthcare

Levi Shapiro

Presentation by Mark Coticchia, Chief Innovation Officer, Baptist Health, for mHealth Israel community, September, 2023. Baptist Health has internationally renowned centers of excellence in cancer, cardiovascular care, orthopedics and sports medicine, and neurosciences. A not-for-profit organization supported by philanthropy and committed to its faith-based charitable mission of medical excellence, Recognized by Fortune as one of the 100 Best Companies to Work For in America and by Ethisphere as one of the World’s Most Ethical Companies.Innovation is paramount to health system’s performance and reputation. Becker’s 2019 Advisory Board survey revealed innovation and technology ranked as the top priority among healthcare finance professionals - up from eighth in 2018. 90% healthcare/life science leaders agree that the pandemic will fundamentally change the way they do business, requiring new products, services, processes, and business models (McKinsey: Innovation Through Crisis Survey). Innovation has been proven to help health systems in many ways. A capability and culture of innovation accomplish numerous goals: Innovation capability and culture improve the care and work environment. They enhance the reputation through recognition for discoveries made at and through Baptist Health. They aid in the recruitment and retention of top talent. And they help systems harness money that otherwise would be leaving the system – licensing revenues and investment returns and corporate research support and donor revenues. Successful Programs - Common Underpinnings. Innovation as a strategic, institutional priority Program built on institutional assets and centers of excellence Experienced, professional team Technology development and sourcing, Dedicated, long term support. Doing healthcare innovation well at a large enterprise takes a highly specialized team and skill set. Collectively, they need to have deep knowledge of healthcare regulation, medical procedures, patient safety, business development, transactions, business law, innovation markets, entrepreneurship, venture capital, commercialization, tech transfer, organizational change management, and much more. Programs- services, technology management, corporate co-creation, global medical service lines and facilities; Focus on market opportunity vs. technology; Select & concentrate on winners; Operate as a business; Proactive in new company formation; Progress, milestones, preliminary results; Building New Innovation Pathways; Improving Treatment for Cancer Patients; Predicting & Preventing Heart Attacks; Improving Outcomes in Cardiac Care; Enhancing a Culture of Innovation at Baptist Health & South Florida; Cleerly, TriVentures, COTA; Innovation is paramount to health system’s performance and reputation. Baptist Health has established an innovation function predicated on best practices and tailored to its assets and the opportunities extending from Miami’s economic growth

YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...

Levi Shapiro

Presentation by Yael Klionsky, YEDA, for the mHealth Israel community in September, 2023. Title: Challenges in Academic Technology Transfer. Examples- Transplantation Immunology and Immunometabolism. Efranat Pharma was developing an anticancer immunotherapy treatment based on a natural plasma protein molecule. From target discovery to clinical validation. Clinical-stage drug discovery and development company utilizing a broadly applicable, predictive computational discovery platforms to identify novel drug targets and new biological pathways and develop therapeutics in the field of cancer immunotherapy. To allow SOCIETY to benefit from discoveries made at the academic institution. To enable SCIENTISTS to transfer their new technologies to the market. To create an additional source of INCOME for the INSTITUTE so that more independent research can be conducted. Three important elements that make an idea patentable: 1) The invention must be new: the same idea can’t have been published before in any form; 2) There must be some inventive step of ‘non-obviousness’. This can be hard to define and depends on the context; 3) The disclosure in a patent must be sufficient for a skilled person to reproduce the invention with only routine effort; Technology Transfer Company - modus operandi; OUR PURPOSE- To provoke transformative scientific breakthroughs that will shape the future of humanity; SCIENTIFIC STAFF- 300 Principal investigators, >2,000 Research students and PhDs; 5 FACULTIES – BASIC SCIENCE, Biology, Physics, Biochemistry, Math/CS Chemistry; Generated IP- 57% in Life Science & Biotech; Among the Highest Income per Researcher Worldwide; 1959 (First TTO outside the US); Today- More applications per PI than in most Ivy league universities; Copaxone- >$30B ANNUAL SALES BASED ON Weizmann IP; 20 new licenses per year and 10 new companies per annum; www.yedarnd.com

HADASIT: Tech Transfer and More in Life Science

Levi Shapiro

Overview of activities in Life Science of Hadasit, the technology transfer arm of Hadassah Hospital in Jerusalem. Includes details about Jerusalem Biodesign program; spinouts like Brainwatch; details about tech transfer (the Secret Engine Behind Israel’s Success); relationship and examples of TTOs enabling Israel's greatest success stories; contrasting of Adademia (Scientific driven research, Creation of new knowledge, Publication, Sharing of Material, Social responsibilities) and Industry (Applied research & specific objectives, Develop new products, Product development, Secrecy and patent protection, Organization responsibilities); Development gap between initial inventions and product development; the Art of translation (from academic research to medical companies); Tech transfer transforms cutting-edge research into marketable healthcare technologies; LICENSING TO EXISTING COMPANIES; SPINNING OFF STARTUPS; CO-DEVELOPMENT OF JOINT IP; Technology Transfer Offices from Academia/Research Hospitals – to Industry; Overview of Hadassah and Hadasit (TECHNOLOGY TRANSFER COMPANY AND INNOVATION ENGINE OF HADASSAH UNIVERSITY HOSPITALS); Examples of “HADASSAH MADE” PRODUCTS IN THE GLOBAL MARKET; RECENT TECH TRANSFER SUCCESS; Example- Lineage Exclusive Worldwide Collaboration with Genentech Opregen® RPE Cell Therapy for the Treatment of Ocular Disorders; HADASIT PILLARS- NURTURING INTERNAL INNOVATION, Tech Transfer, EXTERNAL INNOVATION. External- SERVICES & COLLABORATIONS WITH COMPANIES, BIOHOUSE FOR STARTUPS, DIGITAL HEALTH ACCELERATOR); Internal Innovation- NURTURING INTERNAL INNOVATION, HADASSAH SEED FUND, JERUSALEM BIODESIGN PROGRAM; TYPES OF RELATIONS WITH EXTERNAL COMPANIES- CONSULTING, SAB, CLINICAL TRIALS, R&D SERVICES, DATA LICENCE, ALPHA/BETA SITE, PILOTS, DESIGN PARTNERSHIPS.

Presenting to Investors & the Media.pdf

Levi Shapiro

Presenting to Investors and the Media, lecture by Drew Levinson, LifeSci Communications to mHealth Israel. Three sections: Making a good presentation, Handling interviews with reporters and Answers that resonate. PRESENTING TO INVESTORS AND THE MEDIA- Compelling delivery, Commanding a room, • Lasting Impact. A good presentation includes Information, Motivation and Excitement. Never put them to sleep. Audience impact includes content, credibility and delivery. Decisions are made leading to potential partnerships, winning business, so much more than a deck, your business, your brand, you. How to captivate begins with storytelling and conversation. More than features- benefits, humanize, positive impact. Don't complicate your message with jargon. Feel the passion- contagious, vision, determination. Know your audience- who are they, what do they know about you, how much do they know, interests, concerns. Articulate your vision- see it, feel it, believe in it. Take them on your journey- compelling narrative, make it personal, why are you doing this, inspiration. Your team- experienced, knowledgeable, aligned, execute. Risks and challenges- recognize, address, plan to mitigate. Test drive your room. What does it look like? Where is the podium? Where will I be standing? Where will you be sitting? Feel comfortable. Three parts to attention. The beginning- attention, interest, what's in it for them, entusiasm, preview. The middle- core, insights, challenges, solutions, relatable. The ending- summary, reinforce, messages, benefits, call to action, keep the momentum going. How to answer questions. The Four R's: repeat, reinforce, refer, remember. Talking to reporters- necessity; Good interview can enhance reputation; Bad interview can tarnish reputation; Preparation is vital. Shapes public opinion: Elevates your brand; Establishes authority; Showcases your business; A bridge; Reputation; Trust; Visibility. Know the reporter. Audience; What have they written; Previous stories; Questions asked. Concise- clear, succinct, engaging. Make it relatable: Stories; Anecdotes; Experiences; Examples; Metaphors; Connect. Honesty and transparency. It is okay not to know every answer. You don’t have to answer every question. Control the narrative. What not to do when talking to reporters. Come up with another way to say no comment. What to wear- solid colors, blues and grays, nothing distracting. Expertise, passion, vision, lasting impression, connections. High stakes, high rewards. Preparation; Know your audience; Deliver with confidence; Enthusiasm; Authenticity. Begin the journey. Engage in dialogue; Build relationships; Inspire trust and confidence; Valued; Enlightened; Motivated and excited.

Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...

Levi Shapiro

Beyeonics CEO, Ron Schneider, Advances in Medical XR

Levi Shapiro

Overview by Beyeonics CEO, Ron Schneider, about the company. Beyeonics One is the first ophthalmic exoscope with an augmented reality surgical headset. It is a high-definition, fully digital imaging platform enabling surgeons to see a magnified, three-dimensional (3D) image of the surgical field. The small footprint, the fast setup, automation, and zero turnover time between procedures all contribute to the efficiency operating rooms strive for. Over 3000 cases to date. Unconstrained Movement. Unconstrained workflow. Data connectivity. Designed for continuous innovation.

XRHealth Founder, Miki Levy

Levi Shapiro

XRHealth is revolutionizing healthcare, bringing patient care into the Metaverse. Includes a description of the TeleHealth Platform. Lessons Learned – Building the clinical Metaverse. Last mile delivery Building a product in the Metaverse is easy – getting people to use it is hard. Virtual Care can’t be based only on XR. HMDs bring friction – Charging, Guardian, Safety, Passwords etc. Expanding virtually in a brick & mortar payer environment. Once you cross the chasm – adherence/ satisfaction/retention goes ballistic. Patient Outcomes- Patients report significant improvement in symptoms following treatment. Adherence - patients follow Home Exercise Plans as prescribed. 92.2% with XRHealth vs 50% with regular treatment. Patient satisfaction - 85 NPS vs 38 NPS in healthcare 93.3% patient retention -complete treatment cycle as prescribed. XRHealth Luna AI Reduces Hot Flashes and Improves Psychological Well-Being in Women with Breast and Ovarian Cancer: A Pilot Study. Virtual reality immersion compared to monitored anesthesia care for hand surgery: A randomized controlled trial. Lessons Learned – Autism Spectrum Disorder. The future of the Mediverse.

Digital Health in US Health Systems.pptx

Levi Shapiro

April, 2023 presentation by Gil Bashe, Global Chair, Health Practice, FINN Partners. Insights and analytics, in collaboration with Galen Growth, tracking Digital Health collaboration, adoption, integration, and best practices across the leading US Health Systems. There is a section about focus areas for digital health in health systems and hospitals. The most active health systems are partnering more in diagnosis and have a higher share of digital tools for research. Comprehensive breakout of digital health activities at the Top 10 players: Mayo, Mount Sinai, Cleveland Clinic, Sloan Kettering, Massachusetts General, Northwell, Cedars Sinai, Brigham & Women's, InterMountain. Global breakout of health systems with digital health partnerships at scale. Geographical breakout of digital health partner headquarters (by region). Strong preference for B2B business model. 1/3 of digital health partnerships with Early Stage venture companies. Emphasis is on strong clinical evidence. Portfolio size allows greater diversity. Cluster distribution depends on therapeutic area. Digital health analytics breakout including alpha score, venture similarity score, venture valuation, team signal, partnership signal, evidence signal.

Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...

Levi Shapiro

More from Levi Shapiro (20)

Michigan HealthTech Market Map 2024 with Policy Makers, Academic Innovation C...

June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...

Prix Galien International 2024 Forum Program

mHealth Israel_Healthcare Finance and M&A- What Comes Next

Healthcare Market Overview, May 2024: Funding, Financing and M&A, from Oppenh...

Version Bravo- The Springboard for Navy SEAL entrepreneurship, cohort 003

Radical Life Extension_Dr. Leon Peshkin_Dec 2023

Israel’s Life Science Hub 2023 English Abstract.pdf

Gil Bashe FINN Partners: The Future of Digital Health – Nose Dive or Transfor...

Urgent Request and Call for Action for Ensuring Safety and Inclusivity at MIT

HLTH-2023-Digital-Catalouge.pdf

Baptist Health- Engineering the Future of Healthcare

YEDA Techn Transfer at Weizmann Institute- Discord and Challenges in Academic...

HADASIT: Tech Transfer and More in Life Science

Presenting to Investors & the Media.pdf

Nissan Elimelech, Founder, Augmedics: How I Built the World's First XR Surgic...

Beyeonics CEO, Ron Schneider, Advances in Medical XR

XRHealth Founder, Miki Levy

Digital Health in US Health Systems.pptx

Course Syllabus (Digital Rosh): The Future of Digital Medicine- Biology, Gene...

Recently uploaded

Physiology of Chemical Sensation of smell.pdf

MedicoseAcademics

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx

Bright Chipili

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0 - Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS

AkankshaAshtankar

Role of Mukta Pishti in the Management of Hyperthyroidism

Dr. Jyothirmai Paindla

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

greendigital

Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye. Follow us on: Pinterest Introduction Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing . Early Life and Career Childhood and Athletic Beginnings Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle. Transition to Acting Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness. Fitness Regimen Workout Routine Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show. Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles. Importance of Flexibility and Mobility In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit

263778731218 Abortion Clinic /Pills In Harare ,

sisternakatoto

263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/

Non-respiratory Functions of the Lungs.pdf

MedicoseAcademics

These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract. Learning objectives: 1. Enlist the non-respiratory functions of the respiratory tract 2. Briefly explain how these functions are carried out 3. Discuss the significance of dead space 4. Differentiate between minute ventilation and alveolar ventilation 5. Describe the cough and sneeze reflexes Study Resources: 1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition 3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition 4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Oleg Kshivets

Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).

Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh

Dr. Madduru Muni Haritha

Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.

Top 10 Best Ayurvedic Kidney Stone Syrups in India

Swastik Ayurveda

Netter's Atlas of Human Anatomy 7.ed.pdf

BrissaOrtiz3

Temporomandibular Joint By RABIA INAM GANDAPORE.pptx

Dr. Rabia Inam Gandapore

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Saeid Safari

Cervical & Brachial Plexus By Dr. RIG.pptx

Dr. Rabia Inam Gandapore

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Swetaba Besh

Vision-1.pptx, Eye structure, basics of optics

Sai Sailesh Kumar Goothy

Pictures of Superficial & Deep Fascia.ppt.pdf

Dr. Rabia Inam Gandapore

Identification and nursing management of congenital malformations .pptx

MGM SCHOOL/COLLEGE OF NURSING

Recently uploaded (20)

Physiology of Chemical Sensation of smell.pdf

SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx

Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS

Role of Mukta Pishti in the Management of Hyperthyroidism

Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey

263778731218 Abortion Clinic /Pills In Harare ,

Non-respiratory Functions of the Lungs.pdf

Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...

Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh

Top 10 Best Ayurvedic Kidney Stone Syrups in India

Netter's Atlas of Human Anatomy 7.ed.pdf

Temporomandibular Joint By RABIA INAM GANDAPORE.pptx

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Cervical & Brachial Plexus By Dr. RIG.pptx

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Vision-1.pptx, Eye structure, basics of optics

Pictures of Superficial & Deep Fascia.ppt.pdf

Identification and nursing management of congenital malformations .pptx

Sanofi Digital Transformation and Self Medication_mHealth Israel

1. How Digital Transformation creates new opportunities for self-medication Dr Caty Ebel Bitoun CHC Global Medical Digital Transformation Head April 12th 2021

2. Who we are 2 AROUND THE WORLD OUR TEAMS 100,000+ employees 46.2% women 53.8% men ~145 nationalities We are present in ~100 countries Healthcare solutions available in more than 170 countries TRANSTECH HEALTH APRIL 12TH 2021

3. Sanofi Global Business Unit (GBU) organization 3 3 CORE GBUs FOCUSED ON PRIORITIZED PORTFOLIO Specialty Care — Immunology — Rare Diseases / Rare Blood Disorders — Neurology / Multiple Sclerosis — Oncology General Medicines — Diabetes — Cardiovascular — Established Products Vaccines — Influenza vaccines — Polio Pertussis & Hib, Boosters — Meningitis, others STANDALONE GBU Consumer Healthcare — Allergy, Cough & Cold — Pain — Digestive Health — Mental Wellness TRANSTECH HEALTH APRIL 12TH 2021

4. Sanofi CHC is leading in 4 global OTC categories TRANSTECH HEALTH APRIL 12TH 2021

5. Digital is changing the healthcare landscape Empowering patients / consumers and organising self monitoring 5 TRANSTECH HEALTH APRIL 12TH 2021 https://www.efpia.eu/about-medicines/development-of- medicines/digital-health/

6. How digital improve patient information and product usage with sustainibility value proposition TRANSTECH HEALTH APRIL 12TH 2021 https://www.sanofi-diabete.fr/notre- engagement/actualites/diab-voyage

7. 7 A concrete example from Sanofi France Digital Therapeutic : Opening a new way to manage pain TRANSTECH HEALTH APRIL 12TH 2021

8. 8 A concrete example from Sanofi Venture & Alive Israel HealthTech fund Beyond the pill : How digital helps to self manage medication TRANSTECH HEALTH APRIL 12TH 2021

9. Building the ecosystem

10. Our Ideal partner profile Consumer focus Augmented consumer experience Mature technology including mature business model Scalable more than 2 geographies Proven improvement in health or lifestyle outcome Impact on our consumers Profile of the technology Sustainibility value proposition Easy to purchase (onsite & e-commerce) Data driven claims supported by scientific evidence TRANSTECH HEALTH APRIL 12TH 2021 Compliance cybersecurity and data protection

11. Sanofi has a partner centric philosophy TRANSTECH HEALTH APRIL 12TH 2021

12. THANK YOU Contact: Dr Caty Ebel Bitoun Caty.ebel-bitoun@sanofi.com

Sanofi Digital Transformation and Self Medication_mHealth Israel

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Sanofi Digital Transformation and Self Medication_mHealth Israel

Similar to Sanofi Digital Transformation and Self Medication_mHealth Israel (20)

More from Levi Shapiro

More from Levi Shapiro (20)

Recently uploaded

Recently uploaded (20)

Sanofi Digital Transformation and Self Medication_mHealth Israel